Valuation CSPC Pharmaceutical Group Limited

Stocks

Market Closed - Hong Kong S.E. Other stock markets 12:08:15 03/07/2026 +04			5-day change	1st Jan Change
8.000 ^HKD	+5.96%		+19.58%	-5.10%

06-18	CSPC Pharma's Tumor Drug Gets Trial Nod from US FDA	MT
06-18	CSPC Pharma Unit's Marketing Application for Anti-Inflammatory Drug Accepted in China	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	100,932	97,707	86,022	55,169	96,380	91,464	-	-
Change	-	-3.19%	-11.96%	-35.87%	74.7%	-5.1%	-	-
Enterprise Value (EV) ¹	89,633	86,241	72,284	46,931	86,710	80,413	78,128	75,010
Change	-	-3.79%	-16.18%	-35.07%	84.76%	-7.26%	-2.84%	-3.99%
P/E	14.7x	14.1x	13.5x	12.1x	21.8x	11.1x	13x	11.9x
PBR	3.17x	2.86x	2.39x	1.62x	2.56x	2.14x	1.96x	1.77x
PEG	-	14.13x	-1.73x	-0.5x	-9.88x	0.1x	-0.9x	1.26x
Capitalization / Revenue	2.94x	2.77x	2.52x	1.78x	3.26x	2.57x	2.6x	2.43x
EV / Revenue	2.61x	2.44x	2.12x	1.51x	2.94x	2.26x	2.22x	1.99x
EV / EBITDA	9.5x	9.43x	8.39x	6.22x	12.1x	6.13x	7.91x	7.09x
EV / EBIT	10.7x	10.8x	9.77x	7.68x	15.6x	8.64x	10.2x	9.2x
EV / FCF	23.7x	14.1x	26.2x	17.5x	19.5x	9.78x	11.1x	7.83x
FCF Yield	4.22%	7.11%	3.82%	5.71%	5.12%	10.2%	8.98%	12.8%
Dividend per Share ²	0.18	0.21	0.28	0.26	0.29	0.3591	0.3656	0.3823
Rate of return	2.13%	2.56%	3.86%	5.44%	3.44%	4.49%	4.57%	4.78%
EPS ²	0.5773	0.5831	0.5376	0.3946	0.3859	0.7181	0.6159	0.6739
Distribution rate	31.2%	36%	52.1%	65.9%	75.2%	50%	59.4%	56.7%
Net sales ¹	34,309	35,292	34,175	31,046	29,533	35,562	35,135	37,621
EBITDA ¹	9,431	9,148	8,615	7,547	7,168	13,116	9,883	10,578
EBIT ¹	8,366	7,952	7,400	6,113	5,564	9,309	7,687	8,151
Net income ¹	6,901	6,949	6,382	4,632	4,409	7,903	6,894	7,534
Net Debt ¹	-11,298	-11,467	-13,738	-8,238	-9,670	-11,051	-13,336	-16,454
Reference price ²	8.470	8.200	7.260	4.780	8.430	8.000	8.000	8.000
Nbr of stocks (in thousands)	11,916,370	11,915,520	11,848,756	11,541,665	11,433,025	11,433,025	-	-
Announcement Date	22/03/22	22/03/23	20/03/24	28/03/25	25/03/26	-	-	-

¹HKD in Million²HKD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
CSPC PHARMACEUTICAL GROUP LIMITED	11.14x	2.26x	6.13x	4.49%	11.66B
ELI LILLY AND COMPANY	35.49x	12.89x	26.26x	0.56%	1,082B
JOHNSON & JOHNSON	28.11x	6.46x	17.57x	2.03%	633B
ABBVIE INC.	32.2x	7.69x	15.73x	2.65%	461B
ROCHE HOLDING AG	18.15x	4.51x	11.08x	2.94%	338B
ASTRAZENECA PLC	24.06x	5.03x	14.1x	1.73%	299B
NOVARTIS AG	22.19x	5.69x	13.74x	2.76%	291B
NOVO NORDISK A/S	14.43x	5.37x	11.03x	3.47%	222B
AMGEN INC.	24.39x	6.45x	11.36x	2.7%	202B
GILEAD SCIENCES, INC.	-46.87x	5.66x	31.47x	2.47%	163B
Average	16.33x	6.20x	15.85x	2.58%	370.41B
Weighted average by Cap.	24.70x	8.02x	18.55x	1.94%